전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
het iod-verlagend effect van brimonidine kan langer duren.
the iop-lowering effect of brimonidine may be longer.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
het iod-verlagend effect van azopt als ondersteunende therapie bij de prostaglandine-analoog travoprost werd bestudeerd.
the iop-reducing effect of azopt as adjunctive therapy to the prostaglandin analogue travoprost was studied.
마지막 업데이트: 2017-04-26
사용 빈도: 2
품질:
verder werd het iod-verlagend effect van azopt als ondersteunende therapie bij de prostaglandine-analoog travoprost bestudeerd.
additionally the iop-reducing effect of azopt as adjunctive therapy to the prostaglandin analogue travoprost has been studied.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
de inclusiecriteria waren voor alle studies dezelfde, met uitzondering van het iod-deelnamecriterium en de respons op voorafgaande iod-behandelingen.
inclusion criteria were common across the studies, with the exception of the iop entry criteria and response to previous iop therapy.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
mogelijke terugval effecten na stoppen van de behandeling met azopt zijn niet bestudeerd; er wordt verwacht dat het iod verlagend effect 5-7 dagen duurt.
potential rebound effects following cessation of treatment with azopt have not been studied; the iop- lowering effect is expected to last for 5-7 days.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
hoewel de duur van het iod-verlagingseffect voor simbrinza niet is bestudeerd, zal het iod-verlagend effect van brinzolamide naar verwachting 5-7 dagen duren.
while the duration of iop-lowering effect for simbrinza has not been studied, the iop-lowering effect of brinzolamide is expected to last for 5-7 days.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
in onderzoeken met bimatoprost 0,3 mg/ml bij patiënten met glaucoom of oculaire hypertensie is aangetoond dat vaker blootstellen van het oog aan meer dan één dosis bimatoprost per dag het iod- verlagende effect kan verkleinen.
in studies of bimatoprost 0.3 mg/ml in patients with glaucoma or ocular hypertension, it has been shown that the more frequent exposure of the eye to more than one dose of bimatoprost daily may decrease the iop-lowering effect.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
het iod-verlagende effect van ganfort is niet minder dan het effect van een gecombineerde therapie met bimatoprost (eenmaal daags) en timolol (tweemaal daags).
the iop-lowering effect of ganfort is non-inferior to that achieved by adjunctive therapy of bimatoprost (once daily) and timolol (twice daily).
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
연관성이 낮은 일부 인적 번역은 숨겨져 있습니다.
연관성이 낮은 결과 표시.